InvestorsHub Logo
Followers 240
Posts 12371
Boards Moderated 0
Alias Born 08/14/2003

Re: Chiugray post# 681428

Tuesday, 03/26/2024 9:08:19 PM

Tuesday, March 26, 2024 9:08:19 PM

Post# of 703817
Great post Chiugray,

Of course the only way to really know the worth of NWBO is to continue and expand trials with its products. One extreme is that it only works in GBM and DCVax-Direct doesn't work at all. The other extreme is that both DCVax's work, and should be a part of the SOC in practically every solid cancer.

Aspirin has been around for over a century and they still find new ways to use it. I can imagine that 20 years from now they'll find new ways to use the DCVax's and new products to use in combination with it to make the treatment more effective. I suspect that it will take the better part of a decade for all the results on trials that are initiated in the next couple years to be completed and evaluated, but when approved, both DCVax-L and Direct will be used off label based on anecdotal evidence that shows its benefits.

What does this mean wrt a buyout. To me it's saying that the longer the company waits, and the more they learn, the greater the price will be.

If LP sells before further trials have been done with DCVax-Direct it's likely that they buyer would be stealing the company, no matter how much they paid when compared to the earning potential of the products they're receiving.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News